bioRxiv Science⌕ Search

bioRxiv · 10.64898/2026.09.24.753982

Evaluating Clustering and Imputation Approaches for Multivariate Longitudinal Clinical Data Using a Real-World eCDF-Copula Resampling Framework

Abstract

The rapid growth of technologies such as wearable devices and high-throughput sequencing has generated unprecedented volumes of longitudinal data, often with multiple correlated features. This trend highlights the need for robust clustering methods tailored to multi-feature longitudinal datasets. Although previous reviews have benchmarked clustering methods in this context, most evaluations relied heavily on simulated and overly simplified datasets, which substantially limit their interpretability and applicability to real-world data. Missing data is also ubiquitous in longitudinal data, yet understudied in the context of clustering. To address these gaps, we systematically evaluate clustering methods across three distinct types of real-world longitudinal datasets: (1) a high-dimensional, low-timepoint metagenomic study, (2) a low-dimensional, high-timepoint multi-site repeated-measure study, and (3) a high-dimensional, high-timepoint repeated-measure study. We further investigate how missing data and different imputation strategies influence clustering performance. In addition, we introduce a novel resampling framework based on the empirical cumulative distribution function (eCDF) and a copula. This framework enables us to simulate multi-feature longitudinal data that preserves the correlation structure of real datasets, while also allowing for controlled variations such as sample size. Our simulation framework naturally accommodates missing data, thereby providing a flexible tool for benchmarking and comparing clustering methods in more realistic longitudinal settings.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Cai, H., Xu, K., Osmundson, S., Ajilore, O., Andreescu, C., Taylor, W. D., Liu, J., Zhang, X.. 2026-09-30. Evaluating Clustering and Imputation Approaches for Multivariate Longitudinal Clinical Data Using a Real-World eCDF-Copula Resampling Framework. https://doi.org/10.64898/2026.09.24.753982

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

EMBER: Contextualized gene representations enable compositional prediction across cellular perturbations

Predicting the effects of individual and combined perturbations is central to identifying context-specific vulnerabilities and designing targeted interventions. Yet learning gene representations that integrate functional relationships with cellular state and transfer across perturbation tasks remains challenging. Here, we present EMBER, a gene-centric foundation model that learns context-dependent functional representations of genes. EMBER combines interaction-guided contrastive learning with masked expression reconstruction during pretraining on a single-cell corpus curated for diversity and balanced sampling across cell types and experimental batches. EMBER decouples gene representation learning from task-specific prediction through a composable embedding framework: the pretrained encoder remains frozen, while lightweight probes combine contextualized gene embeddings to predict individual and combined perturbation effects. The same pretrained representations support single-gene perturbation-response prediction, digenic interaction prediction, and multi-target drug-response prediction. EMBER improves cross-context perturbation-response prediction and genetic-interaction ranking relative to evaluated baselines. EMBER also prioritized SCFD1, a mediator of autophagosome-lysosome fusion, as a candidate dependency during mTOR inhibition. Together, these results establish contextualized gene embeddings as reusable building blocks for modeling genetic and pharmacological perturbations, supporting the prioritization of genetic interactions and context-specific interventions for experimental testing.

bioinformatics↗

Small molecule structure elucidation from NMR spectra with generative and reasoning models

Elucidating the structures of unknown small molecules remains a major challenge in chemistry, pharmacology, and drug discovery. While nuclear magnetic resonance (NMR) spectroscopy is the gold standard for structure elucidation, interpreting spectra remains labor-intensive and requires expert knowledge to navigate the vast space of possible structures. Here, we present an AI system for rapid, automated de novo structure elucidation that combines a molecular generative model with a scientific reasoning agent. Its generative component, ChefNMR2, is an atomic flow-matching model that predicts small-molecule structures from molecular formulae and one-dimensional 1H and 13C NMR spectra. ChefNMR2-Agent augments our generative model with large language models (LLMs) to reason over and refine candidate structures. Across diverse benchmarks, ChefNMR2 substantially outperforms existing tools, offering calibrated confidence estimates and two to three orders of magnitude faster inference than frontier LLMs. We use ChefNMR2-Agent to elucidate the structures of four novel natural products, matching human-chemist accuracy in a fraction of the time. Our work demonstrates how specialized generative models and general-purpose reasoning agents can unite to solve challenging scientific inverse problems and accelerate NMR structure elucidation, thus opening new possibilities for AI-driven small-molecule discovery across diverse disciplines.

bioinformatics↗

Digital twins forecast individual immune trajectories

The human immune system differs markedly between individuals and changes in response to infection, vaccination and treatment. AI virtual cells are being built to simulate cellular responses to perturbation. Yet these models, like most immune-response predictors, describe each person by a single pre-challenge measurement and forecast change from patterns pooled across people. Digital twins, updated with every new observation of an individual, could forecast how that person's immune state changes. Here we present ImmuneTwins, which builds these twins from single-cell profiles by personalizing a shared virtual-cell model with each individual's observations. In two external populations, ImmuneTwins reduced immune-age error by 32% and 42% relative to the best existing method. During repeated influenza vaccination, its twins predicted the direction of immune-cell change 35% more accurately than the best published method, and their error fell by 27% as observations accumulated. The twins revealed that immune cells and plasma proteins recover about half their deviation from a persistent personal reference within 90 days, whereas response size varies between challenges. They further localized B-cell remodelling in exceptional longevity and anticipated patient-specific immune trajectories during myeloma treatment. These results establish virtual-cell digital twins for forecasting individual immune change and identifying each person's characteristic immune features.

bioinformatics↗